ChristianaCare finds superior outcomes in Black patients

At ChristianaCare, Black patients are receiving stronger outcomes than national averages for hypertension and heart failure care. 

The U.S. Black population is 12.4%, and at ChristianaCare, 32% of the heart failure patient population is Black — a race that has historically experienced healthcare disparities for heart failure treatment, including low adherence to guideline-directed medical therapy. 

To counteract rates of substandard care, ChristianaCare locked arms with health technology company Story Health, the Newark, Del.-based system said in a Feb. 23 news release.

With Story Health, the system launched a digital platform that offers a health coach who helps with medication adherence, coordinates lab work and aids patients with transportation and prescription assistance. 

Here are the collaboration's results:

  • Six times improvement on target doses of beta blockers (76%)

  • Seven times improvement on target doses of angiotensin converting enzyme inhibitors, angiotensin receptor blockers and angiotensin receptor neprilysin inhibitors (54%)

  • Two times improvement on target doses of mineralocorticoid receptor antagonists (57%)

  • Increase in sodium-glucose cotransporter 2 inhibitor adherence, rising from a 32% baseline to 74%

  • Decrease in average absolute systolic and diastolic blood pressure levels after 120 days

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars